Key points are not available for this paper at this time.
(8th edition, adopted on January 1, 2018), breast cancer staging integrates anatomic staging with tumor grade, biomarker data regarding hormone receptor status, oncogene expression, and gene expression profiling to assign a prognostic stage. This article reviews the 8th edition of the AJCC breast cancer staging system with a focus on anatomic staging and the challenges that anatomic staging poses for radiologists. We highlight key imaging findings that impact patient treatment and discuss the role of imaging in evaluating response to neoadjuvant therapy. Finally, we discuss biomarkers and multigene panels and how these impact prognostic stage. The review will help radiologists identify critical findings that affect breast cancer staging and understand ongoing limitations of imaging in staging.
Building similarity graph...
Analyzing shared references across papers
Loading...
Davis C. Teichgraeber
Mary S. Guirguis
Gary J. Whitman
American Journal of Roentgenology
The University of Texas MD Anderson Cancer Center
Building similarity graph...
Analyzing shared references across papers
Loading...
Teichgraeber et al. (Wed,) studied this question.
www.synapsesocial.com/papers/6a08e0b83589fa5d64d601fb — DOI: https://doi.org/10.2214/ajr.20.25223